Restenosis after percutaneous coronary intervention for coronary chronic total occlusion. The central role of an optimized immediate post-procedural angiographic result

Int J Cardiol. 2016 Dec 1:224:343-347. doi: 10.1016/j.ijcard.2016.09.028. Epub 2016 Sep 16.

Abstract

Background: Factors of restenosis after percutaneous coronary intervention (PCI) for chronic total coronary occlusion (CTO) have not been fully explored. In particular, although the last ACC/AHA guidelines on PCI suggest that a minimum diameter stenosis of 10% with an optimal goal of as close to 0% as possible should be the new benchmark for lesions treated by stenting, angiographic success of PCI for CTO remains in the literature most often defined as a <30% residual diameter stenosis. Whether an optimized immediate post-PCI angiographic result (OAR) defined by a minimal diameter stenosis as close to 0% is associated with a lower restenosis rate in this subset of coronary lesions remains unknown.

Methods: Therefore, we assessed by quantitative coronary analysis (QCA) both the immediate post-PCI and 6-month follow-up angiographic results of 170 successfully treated true CTO.

Results: Post-PCI QCA immediate residual diameter stenosis was <30% in all 170 CTOs and OAR defined as a ≤10% residual stenosis was achieved in 133 (78%). Global binary restenosis rate was 21% in the 170 lesions. Restenosis rates were 46% and 14% in the non-OAR group and in the OAR group, respectively (p<0.0001). Multivariate analysis showed that a non-OAR, a younger age and a retrograde approach were independent factors of restenosis.

Conclusion: Thus, an optimized immediate angiographic result with a minimal diameter stenosis as close to 0% as possible appears to be associated with a lower rate of restenosis after CTO PCI.

Keywords: Chronic total occlusion; Coronary occlusion; Drug-eluting stent; Percutaneous coronary intervention; Restenosis.

MeSH terms

  • Coronary Angiography / methods*
  • Coronary Occlusion* / diagnosis
  • Coronary Occlusion* / diagnostic imaging
  • Coronary Occlusion* / epidemiology
  • Coronary Occlusion* / surgery
  • Coronary Restenosis / diagnosis*
  • Coronary Vessels / diagnostic imaging*
  • Coronary Vessels / surgery
  • Drug-Eluting Stents
  • Female
  • Follow-Up Studies
  • France / epidemiology
  • Humans
  • Long Term Adverse Effects / diagnosis*
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention / adverse effects*
  • Percutaneous Coronary Intervention / instrumentation
  • Percutaneous Coronary Intervention / methods
  • Postoperative Care / methods*
  • Quality Improvement
  • Time Factors